title: Refractory idiopathic pure red cell aplasia complicated by immune thrombocytopenia successfully treated with subcutaneous alemtuzumab.
authors.forename: Dat C
authors.initials: DC
authors.lastname: Pham
authors.forename: Troy H
authors.initials: TH
authors.lastname: Guthrie
authors.forename: Bruce H
authors.initials: BH
authors.lastname: Villas
authors.forename: Elaine
authors.initials: E
authors.lastname: Salazar
mesh_terms: D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy; D007279:Injections, Subcutaneous; D008297:Male; D012010:Red-Cell Aplasia, Pure / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000276:immunology*; D013921:Thrombocytopenia / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D006454:Hemoglobins; D000074323:Alemtuzumab